Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AMN Healthcare Services | AMN | Oct 31, 2024 | 37.94 | -3.75 |
Amneal Pharmaceuticals A | AMRX | Oct 31, 2024 | 8.47 | -1.17 |
Ampco-Pittsburgh | AP | Oct 31, 2024 | 1.75 | -1.13 |
Amphastar Pharmaceuticals | AMPH | Oct 31, 2024 | 50.53 | -0.49 |
Amphenol | APH | Oct 31, 2024 | 67.02 | -1.96 |
Amplify Energy | AMPY | Oct 31, 2024 | 6.62 | -1.34 |
Amplify Online Retail ETF | IBUY | Oct 31, 2024 | 61.31 | -0.10 |
Amplify Transformational Data Sharing ETF | BLOK | Oct 31, 2024 | 40.16 | -3.85 |
Amplitech Group | AMPG | Oct 31, 2024 | 0.99 | -2.94 |
Amplitude A | AMPL | Oct 31, 2024 | 8.99 | -2.39 |
Amprius Technologies | AMPX | Oct 31, 2024 | 1.35 | -10.60 |
AMREP | AXR | Oct 31, 2024 | 30.41 | +1.71 |
AMTD Digital ADR | HKD | Oct 31, 2024 | 3.15 | -8.70 |
AMTD Idea Group ADR | AMTD | Oct 31, 2024 | 1.29 | -4.44 |
Amtech Systems | ASYS | Oct 31, 2024 | 5.56 | -2.11 |
Amylyx Pharmaceuticals | AMLX | Oct 31, 2024 | 5.40 | +2.47 |
AN2 Therapeutics | ANTX | Oct 31, 2024 | 1.08 | -0.92 |
Analog Devices | ADI | Oct 31, 2024 | 223.11 | -3.05 |
AnaptysBio | ANAB | Oct 31, 2024 | 21.63 | -2.48 |
Anavex Life Sciences | AVXL | Oct 31, 2024 | 6.62 | +15.94 |
Andretti Acquisition II Unit | POLEU | Oct 31, 2024 | 9.99 | 0.00 |
Anebulo Pharmaceuticals | ANEB | Oct 31, 2024 | 1.88 | +1.62 |
ANEW Medical | WENA | Oct 31, 2024 | 0.73 | 0.00 |
Angel Oak Financial Strategies | FINS | Oct 31, 2024 | 13.04 | +0.46 |
Angel Oak Mortgage REIT | AOMR | Oct 31, 2024 | 9.02 | -1.74 |
Anghami | ANGH | Oct 31, 2024 | 0.76 | -3.80 |
Angi A | ANGI | Oct 31, 2024 | 2.38 | -1.24 |
AngioDynamics | ANGO | Oct 31, 2024 | 6.69 | -3.46 |
Anglogold Ashanti | AU | Oct 31, 2024 | 27.80 | -2.90 |
Anheuser-Busch InBev ADR | BUD | Oct 31, 2024 | 59.37 | -5.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.